G Medical Innovations Stock Last Dividend Paid
GMVDDelisted Stock | USD 0.33 0.01 2.94% |
G Medical Innovations fundamentals help investors to digest information that contributes to G Medical's financial success or failures. It also enables traders to predict the movement of GMVD Stock. The fundamental analysis module provides a way to measure G Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to G Medical stock.
GMVD |
G Medical Innovations Company Last Dividend Paid Analysis
G Medical's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
CompetitionBased on the recorded statements, G Medical Innovations has a Last Dividend Paid of 0.0. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
All Next | Launch Module |
GMVD Fundamentals
Return On Equity | -8.65 | |||
Return On Asset | -2.23 | |||
Operating Margin | (6.20) % | |||
Current Valuation | 5.92 M | |||
Shares Outstanding | 9.82 M | |||
Shares Owned By Insiders | 15.28 % | |||
Shares Owned By Institutions | 16.91 % | |||
Number Of Shares Shorted | 68.79 K | |||
Price To Book | 6.09 X | |||
Price To Sales | 0.48 X | |||
Revenue | 4.42 M | |||
Gross Profit | 1.5 M | |||
EBITDA | (37.75 M) | |||
Net Income | (25.07 M) | |||
Cash And Equivalents | 6.03 M | |||
Cash Per Share | 0.25 X | |||
Total Debt | 2.09 M | |||
Debt To Equity | 0.44 % | |||
Current Ratio | 1.03 X | |||
Book Value Per Share | (4.82) X | |||
Cash Flow From Operations | (18.48 M) | |||
Short Ratio | 0.31 X | |||
Earnings Per Share | (18.76) X | |||
Target Price | 4.0 | |||
Number Of Employees | 84 | |||
Beta | -1.08 | |||
Market Capitalization | 1.78 M | |||
Total Asset | 4.83 M | |||
Retained Earnings | (115.26 M) | |||
Working Capital | (7.12 M) | |||
Z Score | -59.61 | |||
Net Asset | 4.83 M |
About G Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze G Medical Innovations's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of G Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of G Medical Innovations based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in GMVD Stock
If you are still planning to invest in G Medical Innovations check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G Medical's history and understand the potential risks before investing.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |